UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus

Annals of the rheumatic diseases, 2018-10, Vol.77 (10), p.1507

2018

Volltextzugriff (PDF)

The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis

PloS one, 2016-09, Vol.11 (9), p.e0162306-e0162306

2016

Volltextzugriff (PDF)

Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese

Annals of the rheumatic diseases, 2021-12, Vol.80 (12), p.1575

2021

Volltextzugriff (PDF)

Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease

Annals of the rheumatic diseases, 2022-02, Vol.81 (2), p.278

2022

Volltextzugriff (PDF)

Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications

Arthritis & rheumatology (Hoboken, N.J.), 2015-06, Vol.67 (6), p.1481-1490

2015

Volltextzugriff (PDF)

SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis

Rheumatology (Oxford, England), 2023-05, Vol.62 (5), p.1988-1997

2023

Volltextzugriff (PDF)

Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study

Arthritis research & therapy, 2019-04, Vol.21 (1), p.91-10, Article 91

2019

Volltextzugriff (PDF)

Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study

PloS one, 2019-05, Vol.14 (5), p.e0216624

2019

Volltextzugriff (PDF)

Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis

Annals of the rheumatic diseases, 2017-08, Vol.76 (8), p.1440

2017

Volltextzugriff (PDF)

Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis

Arthritis research & therapy, 2023-03, Vol.25 (1), p.46-46, Article 46

2023

Volltextzugriff (PDF)

Proximal heat stress up-regulates angiopoietin-1 in fingers and reduces the severity of Raynaud's phenomenon in systemic sclerosis: a single-centre pilot study

Modern rheumatology, 2022-02, Vol.32 (2), p.351-357

2022

Volltextzugriff (PDF)

Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody: associated vasculitis—a meta-analysis

Rheumatic & musculoskeletal diseases open, 2020-04, Vol.6 (1), p.e001195

2020

Volltextzugriff (PDF)

Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study

Rheumatology international, 2021-07, Vol.41 (7), p.1233-1241

2021

Volltextzugriff (PDF)

Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study

Clinical rheumatology, 2020-09, Vol.39 (9), p.2563-2572

2020

Volltextzugriff (PDF)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease

Rheumatic & musculoskeletal diseases open, 2023-01, Vol.9 (1), p.e002667

2023

Volltextzugriff (PDF)

Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab

Modern rheumatology, 2015-01, Vol.25 (1), p.134-137

2015

Volltextzugriff (PDF)

Comprehensive exploration of autoantibody in Behçet's disease: A novel autoantibody to claudin-1, an essential protein for tight junctions, is identified

Joint, bone, spine : revue du rhumatisme, 2014-12, Vol.81 (6), p.546-548

2014

Volltextzugriff (PDF)

Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine

Arthritis & rheumatology (Hoboken, N.J.), 2016-11, Vol.68 (11), p.2646-2661

2016

Volltextzugriff (PDF)

Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population

Annals of the rheumatic diseases, 2020-01, Vol.79 (1), p.103

2020

Volltextzugriff (PDF)

OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE

Annals of the rheumatic diseases, 2020-02, Vol.79 (2), p.e17

2020

Volltextzugriff (PDF)

Genomic repertoires linked with pathogenic potency of arthritogenic Prevotella copri isolated from the gut of patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2023-05, Vol.82 (5), p.621

2023

Volltextzugriff (PDF)

Paradoxical improvement of dyspnoea in relapsing polychondritis by glucocorticoid tapering

BMJ case reports, 2024-01, Vol.17 (1)

2024

Volltextzugriff (PDF)

Rapid attenuation of anti–SARS–CoV‐2 antibodies in patients with musculoskeletal diseases in whom intensive immunosuppressive therapies were reinitiated after COVID‐19: comment on the article by Curtis et al

Arthritis & rheumatology (Hoboken, N.J.), 2022-04, Vol.74 (4), p.726-728

2022

Volltextzugriff (PDF)

Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab

Joint, bone, spine : revue du rhumatisme, 2012-01, Vol.79 (1), p.85-87

2012

Volltextzugriff (PDF)

Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study

Modern rheumatology, 2023-07, Vol.33 (4), p.690-699

2023

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

ThemaRheumatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Humans
(25)
Life Sciences & Biomedicine
(24)
Female
(12)
Male
(12)
Middle Aged
(11)
Rheumatoid Arthritis
(11)
Treatment Outcome
(9)
Adult
(7)
Aged
(7)
Arthritis
(7)
Autoimmune Diseases
(7)
Patients
(7)
Retrospective Studies
(7)
Arthritis, Rheumatoid - Drug Therapy
(6)
Disease
(6)
Pathogenesis
(6)
Medicine
(5)
Tocilizumab
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Apoptosis-derived membrane vesicles drive the cGAS-STING pathway and enhance type I IFN production in systemic lupus erythematosus

The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis

Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese

Whole gut virome analysis of 476 Japanese revealed a link between phage and autoimmune disease

Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications

SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis

Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study

Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study

Semaphorin 4D inhibits neutrophil activation and is involved in the pathogenesis of neutrophil-mediated autoimmune vasculitis

Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis

Proximal heat stress up-regulates angiopoietin-1 in fingers and reduces the severity of Raynaud's phenomenon in systemic sclerosis: a single-centre pilot study

Efficacy of mycophenolate mofetil as a remission induction therapy in antineutrophil cytoplasmic antibody: associated vasculitis—a meta-analysis

Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study

Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease

Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab

Comprehensive exploration of autoantibody in Behçet's disease: A novel autoantibody to claudin-1, an essential protein for tight junctions, is identified

Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine

Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population

OCTA, a sensitive screening for asymptomatic retinopathy, raises alarm over systemic involvements in patients with SLE

Genomic repertoires linked with pathogenic potency of arthritogenic Prevotella copri isolated from the gut of patients with rheumatoid arthritis

Paradoxical improvement of dyspnoea in relapsing polychondritis by glucocorticoid tapering

Rapid attenuation of anti–SARS–CoV‐2 antibodies in patients with musculoskeletal diseases in whom intensive immunosuppressive therapies were reinitiated after COVID‐19: comment on the article by Curtis et al

Psoriatic arthritis in two patients with an inadequate response to treatment with tocilizumab

Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort study

Aktive Filter

Suchergebnisse filtern